Olodaterol Oral Inhalation

316 interactions 36 cited references

Also sold as: Striverdi Striverdi® Respimat®

About Olodaterol Oral Inhalation

Olodaterol oral inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and emphysema). Olodaterol oral inhalation is in a class of medicatio… Read the full Olodaterol Oral Inhalation drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 247 Major 57 Moderate

All (316) Contraindicated (12) Major (247) Moderate (57)

Major

Olodaterol Oral Inhalation Propafenone Rythmol An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Propranolol Hemangeol Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Protriptyline An increased risk of QT interval prolongation, an increased risk of ventricular arrhythmias and potentiated cardiovascular effects Details Olodaterol Oral Inhalation Pseudoephedrine Afrinol® An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Quetiapine Seroquel An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Quinidine Cardioquin® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Quinine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ranolazine Aspruzyo An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Rasagiline Azilect Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Ribociclib Kisqali An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Rilpivirine Edurant An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Risperidone Perseris An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ritonavir Norvir An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Safinamide Xadago Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Salmeterol Serevent An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Selegiline Anipryl Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Selpercatinib Retevmo An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sertindole An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sertraline An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sevoflurane Petrem An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Siponimod Mayzent An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sodium Phosphate OsmoPrep An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sodium Phosphate, Dibasic An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sodium Phosphate, Monobasic An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Solifenacin Vesicare An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sorafenib Nexavar An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sotalol Betapace Reduced olodaterol exposure and reduced sotalol exposure and an increased risk of QT interval prolongation and ventricular arrhyth... Details Olodaterol Oral Inhalation Sulpiride An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sultopride An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Sunitinib Sutent An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Tacrolimus Astagraf An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Taletrectinib Ibtrozi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Tamoxifen Nolvadex® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Telaprevir An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Telavancin Vibativ An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Telithromycin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Terbutaline Brethine® An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Tetrabenazine Xenazine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Tetrahydrozoline An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Tianeptine Potentiated cardiovascular effects Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.